Joseph Harmon, MD
Obstetrics · Calhoun, GANPI 1265865885
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,846 of the $2,697 with a category attached, or 68.5%. Coloplast accounts for 78.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $2,089, more than ten times the $129 reported in 2019.
Across 45 payments — averaging $59.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- AbbVie$250
- Intuitive Surgical$60
- Daiichi Sankyo Inc.$45
- Aspira Women's Health Inc$43
- Hologic Sales And Service, LLC$36
- plus $137 from 6 others
What the payments were for
- Travel & lodging$1,84668%
- Food & beverage$85032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 11 | $2,126 |
| AbbVie | 18 | $250 |
| Intuitive Surgical | 1 | $60 |
| Daiichi Sankyo Inc. | 3 | $45 |
| Aspira Women's Health Inc | 1 | $43 |
| Hologic Sales And Service, LLC | 3 | $36 |
| Roche Diagnostics Corporation | 2 | $32 |
| Therapeuticsmd, Inc. | 2 | $27 |
| Organon | 1 | $26 |
| Minerva Surgical, Inc | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$1,846
How this compares
$2,697 in reported general payments places this provider in the 75th percentile of 41 obstetrics providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 33 | $20,196 |
| GemtesaVibegron | 18 | $9,608 |
| Estradiol | 73 | $4,385 |
| Norethindrone Acetate | 39 | $875 |
| Estradiol (Twice Weekly)Estradiol | 15 | $631 |
| Medroxyprogesterone Acetate | 56 | $576 |
| Solifenacin Succinate | 16 | $203 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $191 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Calhoun
- Daniel YorkMoultrie$15K
- Hector Caceres SerranoVilla Rica$7K
- Anna CarterSnellville$6K
- Michelle UzorConyers$5K
- Rebecca FletcherAthens$4K
- Shannon RenfrowFot Stewart$4K
- Connie OsorioGainesville$4K
- Kalie VinsonAtlanta$3K
- John LeeSuwanee$3K
- E Davis-WilliamsAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.